Another study by Yoshiaki et al. revealed that a BET inhibitor combined with a MEK inhibitor effectively overcame the intrinsic resistance to JQ1 and repressed the growth of colon cancer cells by further decreasing the expression of c-MYC [99]. Here, MYC is linked to malignant colon neoplasm.